Sunday, May 27, 2018

Best Casino Stocks To Own For 2019

tags:INO,CLS,STOR, &l;p&g;Imagine you are at a roulette table in a casino and are given an opportunity for your lifetime savings of $500,000. You have two choices, A and B. If you choose option A, you will receive a monthly paycheck of $2,000 for the rest of your life. With option B, you could receive a monthly paycheck of $5,000 for the rest of your life.

The choice seems obvious, right? Not quite. If you read it correctly, option B does not offer the certainty of option A. The word &a;lsquo;could&a;rsquo; expresses possibility &a;ndash; and only possibility. That means there is a risk involved &a;ndash; a spin on the wheel. If it lands on red, you will receive the $5,000 monthly paycheck for the rest of your life, but if it lands on black, you receive nothing. Now, what do you do? Is the reward worth the risk?

That is the BIG question! Since I began focusing on income planning in 2005, four out of five clients I meet face this decision: the known versus the unknown, the certainty of a paycheck versus the possibility of making more money in the market. We refer to it as &a;lsquo;income planning&a;rsquo; versus &a;lsquo;income guessing.&a;rsquo;

Best Casino Stocks To Own For 2019: Inovio Pharmaceuticals, Inc.(INO)

Advisors' Opinion:
  • [By Joseph Griffin]

    Inovio Pharmaceuticals (NASDAQ:INO) last posted its earnings results on Wednesday, May 9th. The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.22). Inovio Pharmaceuticals had a negative net margin of 292.06% and a negative return on equity of 72.04%. The company had revenue of $1.53 million during the quarter, compared to analyst estimates of $7.50 million. During the same quarter last year, the business posted ($0.31) EPS. research analysts expect that Inovio Pharmaceuticals Inc will post -1.2 EPS for the current fiscal year.

  • [By Jim Robertson]

    On Tuesday, small cap�Inovio Pharmaceuticals (NASDAQ: INO) surged 22.63% after announcing�that its synthetic vaccine approach using a collection of synthetic DNA antigens generated broad protective antibody responses against all major deadly strains of H1 influenza viruses from the last 100 years. This includes�the virus that caused ��Spanish Flu�� in 1918. The study involved�multiple animal models, including mice, guinea pigs and non-human primates. Given how bad flu season is this year, the announcement got plenty of attention as�the following technical chart shows:��

Best Casino Stocks To Own For 2019: Celestica, Inc.(CLS)

Advisors' Opinion:
  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newsletter suggestion as the next breakout stock, and�mid cap Flextronics International being bigger winners (albeit FLEX has steadily risen for two years while SANM has already peaked) compared with the moderately positive performance of mid cap Jabil Circuit, Inc (NYSE: JBL) and small cap Celestica Inc (NYSE: CLS):

  • [By Peter Graham]

    Nevertheless, a long term performance chart shows Sanmina Corp previously being an outperformer, but now falling off while�potential large cap peer Flextronics International Ltd (NASDAQ: FLEX) has given a steady performance over the last two years and small cap�Celestica Inc (NYSE: CLS) and mid cap�Jabil Circuit, Inc (NYSE: JBL) have similar unaspiring charts:

  • [By Ethan Ryder]

    These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get Celestica alerts: Global White Box Server Market Trend 2018- Quanta, Wistron, Inventec, Hon Hai, MiTAC, Celestica, Super Micro … (nwctrail.com) Taking Aim at Celestica Inc (CLS) Shares (parkcitycaller.com) When to Buy Opportunity? Celestica Inc. (CLS) (nysestocks.review) Electronic Manufacturing Services (EMS) Market 2018: Global Analysis by Key Players �� Foxconn, Flextronics, Celestica (industrytoday.co.uk) Riveting Stock Watch: Celestica Inc. (TSX:CLS) Earnings Growth in the Spotlight (derbynewsjournal.com)

    A number of equities research analysts have recently issued reports on the company. TheStreet upgraded Celestica from a “c+” rating to a “b-” rating in a research note on Monday, May 7th. Zacks Investment Research cut Celestica from a “hold” rating to a “sell” rating in a research note on Thursday, May 3rd. Royal Bank of Canada upped their price objective on Celestica from $11.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Monday, April 30th. Finally, Beacon Securities reiterated a “buy” rating on shares of Celestica in a research note on Monday, January 29th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $13.27.

Best Casino Stocks To Own For 2019: STORE Capital Corporation(STOR)

Advisors' Opinion:
  • [By Shane Hupp]

    Stevens Capital Management LP bought a new position in shares of STORE Capital (NYSE:STOR) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund bought 24,795 shares of the real estate investment trust’s stock, valued at approximately $615,000.

  • [By Todd Campbell, Rich Smith, and Neha Chamaria]

    Dividend paying stocks historically outperform non-dividend paying stocks, but that doesn't mean that all dividend paying companies are created equal. Some businesses are better than others, and the best businesses offer the greatest opportunity for future dividend increases. If you're hunting for top dividend stocks that offer more than just a high yield, it could be time to consider buying�CVS Health (NYSE:CVS), Welltower (NYSE:WELL), and STORE Capital (NYSE:STOR).

  • [By Lee Jackson]

    STORE Capital Corp. Inc. (NYSE: STOR) is the leader in the acquisition, investment and management of Single Tenant Operational Real Estate, which is its target market. Investors receive a 4.94% yield, and shares traded recently at $24.85. The 52-week range is $19.65 to $26.58. The consensus price target is $27.08.

  • [By Brian Feroldi, Leo Sun, and Demitrios Kalogeropoulos]

    Want proof? We asked these Motley Fool investors to highlight a dividend stock that pays a higher yield than Verizon. Here's why they picked�Tanger Factory Outlets (NYSE:SKT), Cedar Fair (NYSE:FUN), and�STORE Capital (NYSE:STOR).�

  • [By Keith Speights]

    Verizon Communications (NYSE:VZ), Store Capital Corporation (NYSE:STOR), and Sanofi (NYSE:SNY) are three Warren Buffett stocks that have especially high dividend yields of more than 4%. What does the Oracle of Omaha like about these stocks -- and are they smart picks for other investors right now?

No comments:

Post a Comment